SCHEDULE: Bleichroeder LP Discloses Modular Medical Stake

Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach have filed a Schedule 13G, reporting beneficial ownership of 6.23% of Modular Medical, Inc. common shares.

Summary

• Bleichroeder LP, Bleichroeder Holdings LLC, and Andrew Gundlach have jointly filed a Schedule 13G, indicating their beneficial ownership of Modular Medical, Inc. common shares.
• The reporting persons collectively own 336,986 shares, representing 6.23% of the outstanding common stock as of June 30, 2026.
• Bleichroeder LP, an investment adviser, is the primary entity deemed beneficial owner due to its advisory role for various clients.
• Additionally, Bleichroeder LP holds 110,092 shares issuable upon exercise of warrants, subject to a 4.99% beneficial ownership limitation.
• If the warrant exercise limitation were not in place, the total beneficial ownership would be 447,078 shares, or 8.09% of the outstanding stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative disclosure of beneficial ownership rather than a strategic or financial update.

Positives

• Disclosure of significant beneficial ownership by an investment adviser, indicating potential investor interest.
• The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control.

Negatives

• The filing does not provide any financial performance data or strategic updates for Modular Medical, Inc.
• The potential ownership percentage is capped by a beneficial ownership limitation on warrants, suggesting a cautious approach or regulatory constraint.

Risks

• The beneficial ownership limitation of 4.99% on warrant exercise could restrict future increases in stake.
• The filing does not offer insights into the underlying performance or future prospects of Modular Medical, Inc., leaving investment decisions based on external analysis.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Modular Medical, Inc.'s future performance. It solely pertains to the reporting of beneficial ownership.

Management Comments

• The reporting persons certify that the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors crossing certain ownership thresholds. This filing indicates a notable stake by Bleichroeder LP in Modular Medical, Inc., a medical device company, but provides no operational or financial insights into the company itself.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant beneficial owner, which may influence market perception.
• Management of Modular Medical, Inc.: Awareness of a substantial shareholder stake can inform strategic discussions and governance considerations.

Next Steps

• The reporting persons will file subsequent amendments to the Schedule 13G as necessary.
• The reporting persons will be responsible for the timely filing of amendments and the accuracy of information concerning themselves.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Investment Adviser, Modular Medical, Common Shares, Warrants, Bleichroeder LP